首页 > 最新文献

Kidney Medicine最新文献

英文 中文
Living Donor Candidates’ Self-reported Health and Health Perceptions and Completion of Donor Evaluation: A Cohort Study 活体捐献者候选人的自我健康报告和健康认知与捐献者评估的完成情况:队列研究
IF 3.2 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 DOI: 10.1016/j.xkme.2024.100909
<div><h3>Rationale & Objective</h3><div>Given the organ shortage in the United States, increasing living donation is vital to improving access to kidney transplantation, but many donor candidates do not complete the donor evaluation. Our objective was to understand potential living donors’ perceived health and its association with the likelihood of completing the donor evaluation process.</div></div><div><h3>Study Design</h3><div>Potential donors’ self-reported health was ascertained using the Patient Reported Outcomes Measurement Information System (PROMIS) global physical and mental health and the Davies and Ware Health Perceptions surveys.</div></div><div><h3>Setting & Participants</h3><div>Potential living donors who expressed interest in donation at a single medical center were recruited prospectively between 2017 and 2022.</div></div><div><h3>Exposure</h3><div>Donors' self-reported health and health perceptions.</div></div><div><h3>Outcomes</h3><div>Completion of the donor evaluation.</div></div><div><h3>Analytical Approach</h3><div>Adjusted linear and logistic regression models were used to examine the association between self-reported health and health perceptions with outcomes.</div></div><div><h3>Results</h3><div>A total of 1,347 individuals were included for study; 46% (N<!--> <!-->=<!--> <!-->613) were<!--> <!--><<!--> <!-->40 years of age, 71% (n<!--> <!-->=<!--> <!-->951) were female, 22% (n<!--> <!-->=<!--> <!-->294) were of Hispanic ethnicity, and 16% (n<!--> <!-->=<!--> <!-->215) completed the donor evaluation. The mean PROMIS global physical health (17.0<!--> <!-->±<!--> <!-->1.9) and mental health (15.5<!--> <!-->±<!--> <!-->2.7) raw scores were higher among donor candidates proceeding to completion of the donor evaluation when compared with those who withdrew early in the process (16.3<!--> <!-->±<!--> <!-->2.2 for physical health and 14.9<!--> <!-->±<!--> <!-->3.1 for mental health). Every z-score change in the PROMIS physical health score was associated with 1.48-fold higher odds of completing the donor evaluation (95% CI, 1.19-1.85). Fully adjusted models incorporating the PROMIS scores for predicting the completion of donor evaluations had a c-statistic of 0.70. Potential donors’ Davies and Wares health perceptions did not predict the likelihood of completing the donor evaluation in fully adjusted models.</div></div><div><h3>Limitations</h3><div>Data are derived from a single center and may not generalize to the donor evaluation process at other transplant centers.</div></div><div><h3>Conclusions</h3><div>Donor candidates’ self-reported physical health may serve as a predictor of the likelihood of completing the donor evaluation process and a potential avenue for future interventions.</div></div><div><h3>Plain Language Summary</h3><div>This study was designed to understand the health perceptions of living donor candidates. We found that donor candidates’ self-reported physical health strongly predicted their lik
研究理由与目标鉴于美国器官短缺,增加活体捐献对改善肾移植的可及性至关重要,但许多捐献者候选人并未完成捐献者评估。我们的目的是了解潜在活体捐献者的感知健康状况及其与完成捐献者评估过程的可能性之间的关系。研究设计使用患者报告结果测量信息系统(PROMIS)全球身心健康和戴维斯与瓦尔健康感知调查来确定潜在捐献者的自我报告健康状况。暴露捐献者自我报告的健康状况和健康感知.结果完成捐献者评估.分析方法使用调整线性和逻辑回归模型来检验自我报告的健康状况和健康感知与结果之间的关联。结果共有 1347 人被纳入研究;46%(n = 613)的年龄为 40 岁,71%(n = 951)为女性,22%(n = 294)为西班牙裔,16%(n = 215)完成了捐献评估。与早期退出评估过程的捐献者相比,PROMIS 全球身体健康(17.0 ± 1.9)和心理健康(15.5 ± 2.7)平均原始分在完成捐献者评估的捐献者候选人中更高(身体健康为 16.3 ± 2.2,心理健康为 14.9 ± 3.1)。PROMIS身体健康评分每变化一个z分数,完成捐献者评估的几率就会增加1.48倍(95% CI,1.19-1.85)。包含 PROMIS 分数的预测捐赠者评估完成情况的完全调整模型的 c 统计量为 0.70。在完全调整模型中,潜在捐献者的戴维斯和瓦尔斯健康感知并不能预测完成捐献者评估的可能性。结论捐献者候选人自我报告的身体健康状况可能是完成捐献者评估过程可能性的预测因素,也是未来干预的潜在途径。我们发现,捐献者候选人自我报告的身体健康状况强烈预示着他们完成捐献者评估过程的可能性。我们需要进一步研究,以了解解决捐献者对健康的自我认知问题是否能提高捐献者评估的完成率。
{"title":"Living Donor Candidates’ Self-reported Health and Health Perceptions and Completion of Donor Evaluation: A Cohort Study","authors":"","doi":"10.1016/j.xkme.2024.100909","DOIUrl":"10.1016/j.xkme.2024.100909","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Rationale &amp; Objective&lt;/h3&gt;&lt;div&gt;Given the organ shortage in the United States, increasing living donation is vital to improving access to kidney transplantation, but many donor candidates do not complete the donor evaluation. Our objective was to understand potential living donors’ perceived health and its association with the likelihood of completing the donor evaluation process.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Study Design&lt;/h3&gt;&lt;div&gt;Potential donors’ self-reported health was ascertained using the Patient Reported Outcomes Measurement Information System (PROMIS) global physical and mental health and the Davies and Ware Health Perceptions surveys.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Setting &amp; Participants&lt;/h3&gt;&lt;div&gt;Potential living donors who expressed interest in donation at a single medical center were recruited prospectively between 2017 and 2022.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Exposure&lt;/h3&gt;&lt;div&gt;Donors' self-reported health and health perceptions.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Outcomes&lt;/h3&gt;&lt;div&gt;Completion of the donor evaluation.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Analytical Approach&lt;/h3&gt;&lt;div&gt;Adjusted linear and logistic regression models were used to examine the association between self-reported health and health perceptions with outcomes.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;A total of 1,347 individuals were included for study; 46% (N&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;613) were&lt;!--&gt; &lt;!--&gt;&lt;&lt;!--&gt; &lt;!--&gt;40 years of age, 71% (n&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;951) were female, 22% (n&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;294) were of Hispanic ethnicity, and 16% (n&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;215) completed the donor evaluation. The mean PROMIS global physical health (17.0&lt;!--&gt; &lt;!--&gt;±&lt;!--&gt; &lt;!--&gt;1.9) and mental health (15.5&lt;!--&gt; &lt;!--&gt;±&lt;!--&gt; &lt;!--&gt;2.7) raw scores were higher among donor candidates proceeding to completion of the donor evaluation when compared with those who withdrew early in the process (16.3&lt;!--&gt; &lt;!--&gt;±&lt;!--&gt; &lt;!--&gt;2.2 for physical health and 14.9&lt;!--&gt; &lt;!--&gt;±&lt;!--&gt; &lt;!--&gt;3.1 for mental health). Every z-score change in the PROMIS physical health score was associated with 1.48-fold higher odds of completing the donor evaluation (95% CI, 1.19-1.85). Fully adjusted models incorporating the PROMIS scores for predicting the completion of donor evaluations had a c-statistic of 0.70. Potential donors’ Davies and Wares health perceptions did not predict the likelihood of completing the donor evaluation in fully adjusted models.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Limitations&lt;/h3&gt;&lt;div&gt;Data are derived from a single center and may not generalize to the donor evaluation process at other transplant centers.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;Donor candidates’ self-reported physical health may serve as a predictor of the likelihood of completing the donor evaluation process and a potential avenue for future interventions.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Plain Language Summary&lt;/h3&gt;&lt;div&gt;This study was designed to understand the health perceptions of living donor candidates. We found that donor candidates’ self-reported physical health strongly predicted their lik","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142554192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Undetected Air Embolism During Hemodialysis from a Defective Central Venous Catheter Causing Intradialytic Cardiac Arrest: An Imaging Teaching Case 血液透析过程中因中心静脉导管缺陷而未被发现的空气栓塞导致析出内心脏骤停:影像学教学病例
IF 3.2 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-10-16 DOI: 10.1016/j.xkme.2024.100915
{"title":"Undetected Air Embolism During Hemodialysis from a Defective Central Venous Catheter Causing Intradialytic Cardiac Arrest: An Imaging Teaching Case","authors":"","doi":"10.1016/j.xkme.2024.100915","DOIUrl":"10.1016/j.xkme.2024.100915","url":null,"abstract":"","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142537384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Surprise Question in Hemodialysis, Frailty, Nutrition, Patient-reported Quality of Life, and All-Cause Mortality: The Osaka Dialysis Complication Study (ODCS) 血液透析、虚弱、营养、患者报告的生活质量和全因死亡率中的意外问题:大阪透析并发症研究(ODCS)
IF 3.2 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-10-11 DOI: 10.1016/j.xkme.2024.100914
<div><h3>Rationale & Objective</h3><div>A response “no” (SQ-No) to the surprise question (SQ) of whether a clinician would be surprised if a dialysis patient died in the next 6 months is associated with a higher risk of all-cause death. It is uncertain what domains are intuitively assessed with the SQ. We hypothesized that the SQ would assess the patient’s frailty, malnutrition, or patient-perceived health-related quality of life in a cohort of patients on maintenance hemodialysis.</div></div><div><h3>Study Design</h3><div>Cohort study.</div></div><div><h3>Setting & Participants</h3><div>A multicenter study including 994 patients on maintenance hemodialysis in Japan.</div></div><div><h3>Predictors</h3><div>(1) SQ answered by nurses; (2) frailty by modified Cardiovascular Health Study criteria; (3) malnutrition as evaluated by Geriatric Nutritional Risk Index (GNRI); and (4) patient-perceived health-related quality of life examined by the 36-Item Short Form Health Survey (SF-36) physical component summary (PCS).</div></div><div><h3>Outcomes</h3><div>All-cause mortality.</div></div><div><h3>Analytical Approach</h3><div>Cox proportional hazard models.</div></div><div><h3>Results</h3><div>Median age and dialysis vintage were 66 and 5.9 years, respectively, 35.8% were women, and 39.6% had diabetic kidney disease. The prevalence of SQ-No and frailty was 19.7% and 45.9%. Median GNRI and SF-36 PCS scores were 96.3 and 36.9, respectively. During the 5-year follow-up, 247 patients died. SQ-No, being frail, low GNRI, and low SF-36 PCS were each significant predictors of a higher risk for mortality independent of potential confounders. SQ-No remained a significant predictor after further adjustment for frailty or GNRI, but SQ-No was no longer significant when adjusted for SF-36 PCS.</div></div><div><h3>Limitations</h3><div>We did not assess the agreement of responses to the SQ between different raters.</div></div><div><h3>Conclusions</h3><div>The predictive ability of the SQ was closely related to SF-36 PCS in hemodialysis patients. Nurses’ answer to the SQ appears to assess the physical domain of patient-perceived health-related quality of life rather than objectively assessed frailty or malnutrition.</div></div><div><h3>Plain Language Summary</h3><div>“Would I be surprised if this patient died in the next 6 months?” This question posed to a clinician is called the “surprise question” (SQ) and the answer “no” (SQ-No) has been shown to predict a higher risk of mortality in patients undergoing hemodialysis. We examined which domains are intuitively assessed with the SQ, such as frailty, malnutrition, and patient-perceived quality of life in a cohort of hemodialysis patients. We found that the association between the SQ response and mortality was independent of frailty and malnutrition but was closely related to the physical domain of patient-perceived quality of life. The results suggest that the SQ appears to assess the physical domain of patient-per
理由和ampamp; 目标对 "如果透析患者在未来 6 个月内死亡,临床医生是否会感到惊讶 "的惊讶问题(SQ)回答 "不会"(SQ-No)与较高的全因死亡风险有关。目前还不确定 SQ 可以直观地评估哪些领域。我们假设,在一组维持性血液透析患者中,SQ 将评估患者的虚弱、营养不良或患者感知的健康相关生活质量。预测因素(1) 护士回答的 SQ;(2) 根据修改后的心血管健康研究标准评估的虚弱程度;(3) 根据老年营养风险指数 (GNRI) 评估的营养不良程度;(4) 根据 36 项简表健康调查 (SF-36) 身体成分摘要 (PCS) 评估的患者感知的健康相关生活质量。结果全因死亡率。分析方法Cox比例危险模型。结果中位年龄和透析年份分别为66岁和5.9年,35.8%为女性,39.6%患有糖尿病肾病。SQ-No和虚弱的发生率分别为19.7%和45.9%。GNRI 和 SF-36 PCS 评分的中位数分别为 96.3 分和 36.9 分。在 5 年的随访中,有 247 名患者死亡。独立于潜在的混杂因素,SQ-No、体弱、低 GNRI 和低 SF-36 PCS 均可显著预测较高的死亡风险。在进一步调整虚弱程度或 GNRI 后,SQ-No 仍是一个重要的预测因子,但在调整 SF-36 PCS 后,SQ-No 不再重要。护士对 SQ 的回答似乎评估的是患者感知的健康相关生活质量中的生理领域,而不是客观评估的体弱或营养不良。向临床医生提出的这个问题被称为 "惊喜问题"(SQ),答案 "不"(SQ-No)已被证明可预测血液透析患者的较高死亡风险。我们在一组血液透析患者中研究了 SQ 可以直观评估的领域,如虚弱、营养不良和患者感知的生活质量。我们发现,SQ 反应与死亡率之间的关系与虚弱和营养不良无关,但与患者感知的生活质量的物理领域密切相关。结果表明,SQ 似乎是评估患者感知的健康相关生活质量中的身体领域,而不是客观评估的虚弱或营养不良。
{"title":"The Surprise Question in Hemodialysis, Frailty, Nutrition, Patient-reported Quality of Life, and All-Cause Mortality: The Osaka Dialysis Complication Study (ODCS)","authors":"","doi":"10.1016/j.xkme.2024.100914","DOIUrl":"10.1016/j.xkme.2024.100914","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Rationale &amp; Objective&lt;/h3&gt;&lt;div&gt;A response “no” (SQ-No) to the surprise question (SQ) of whether a clinician would be surprised if a dialysis patient died in the next 6 months is associated with a higher risk of all-cause death. It is uncertain what domains are intuitively assessed with the SQ. We hypothesized that the SQ would assess the patient’s frailty, malnutrition, or patient-perceived health-related quality of life in a cohort of patients on maintenance hemodialysis.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Study Design&lt;/h3&gt;&lt;div&gt;Cohort study.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Setting &amp; Participants&lt;/h3&gt;&lt;div&gt;A multicenter study including 994 patients on maintenance hemodialysis in Japan.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Predictors&lt;/h3&gt;&lt;div&gt;(1) SQ answered by nurses; (2) frailty by modified Cardiovascular Health Study criteria; (3) malnutrition as evaluated by Geriatric Nutritional Risk Index (GNRI); and (4) patient-perceived health-related quality of life examined by the 36-Item Short Form Health Survey (SF-36) physical component summary (PCS).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Outcomes&lt;/h3&gt;&lt;div&gt;All-cause mortality.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Analytical Approach&lt;/h3&gt;&lt;div&gt;Cox proportional hazard models.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Median age and dialysis vintage were 66 and 5.9 years, respectively, 35.8% were women, and 39.6% had diabetic kidney disease. The prevalence of SQ-No and frailty was 19.7% and 45.9%. Median GNRI and SF-36 PCS scores were 96.3 and 36.9, respectively. During the 5-year follow-up, 247 patients died. SQ-No, being frail, low GNRI, and low SF-36 PCS were each significant predictors of a higher risk for mortality independent of potential confounders. SQ-No remained a significant predictor after further adjustment for frailty or GNRI, but SQ-No was no longer significant when adjusted for SF-36 PCS.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Limitations&lt;/h3&gt;&lt;div&gt;We did not assess the agreement of responses to the SQ between different raters.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;The predictive ability of the SQ was closely related to SF-36 PCS in hemodialysis patients. Nurses’ answer to the SQ appears to assess the physical domain of patient-perceived health-related quality of life rather than objectively assessed frailty or malnutrition.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Plain Language Summary&lt;/h3&gt;&lt;div&gt;“Would I be surprised if this patient died in the next 6 months?” This question posed to a clinician is called the “surprise question” (SQ) and the answer “no” (SQ-No) has been shown to predict a higher risk of mortality in patients undergoing hemodialysis. We examined which domains are intuitively assessed with the SQ, such as frailty, malnutrition, and patient-perceived quality of life in a cohort of hemodialysis patients. We found that the association between the SQ response and mortality was independent of frailty and malnutrition but was closely related to the physical domain of patient-perceived quality of life. The results suggest that the SQ appears to assess the physical domain of patient-per","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advanced CKD of Uncertain Etiology Among Children in Guatemala: Genetic and Clinical Characteristics 危地马拉儿童病因不明的晚期 CKD:遗传和临床特征
IF 3.2 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.xkme.2024.100910
{"title":"Advanced CKD of Uncertain Etiology Among Children in Guatemala: Genetic and Clinical Characteristics","authors":"","doi":"10.1016/j.xkme.2024.100910","DOIUrl":"10.1016/j.xkme.2024.100910","url":null,"abstract":"","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142586707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pegloticase-Induced Rapid Uric Acid Lowering and Kidney and Cardiac Health Markers in Youth-Onset Type 2 Diabetes: A Pilot Clinical Trial Pegloticase诱导的快速尿酸降低以及青年 2 型糖尿病患者的肾脏和心脏健康指标:试点临床试验
IF 3.2 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.xkme.2024.100911
{"title":"Pegloticase-Induced Rapid Uric Acid Lowering and Kidney and Cardiac Health Markers in Youth-Onset Type 2 Diabetes: A Pilot Clinical Trial","authors":"","doi":"10.1016/j.xkme.2024.100911","DOIUrl":"10.1016/j.xkme.2024.100911","url":null,"abstract":"","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antihypertensive Treatment Patterns in CKD Stages 3 and 4: The CKD-REIN Cohort Study CKD 3 期和 4 期患者的抗高血压治疗模式:CKD-REIN 队列研究
IF 3.2 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.xkme.2024.100912
<div><h3>Rationale & Objective</h3><div>Blood pressure (BP) control is essential for preventing cardiorenal complications in chronic kidney disease (CKD), but most patients fail to reach BP target. We assessed longitudinal patterns of antihypertensive drug prescription and systolic BP.</div></div><div><h3>Study Design</h3><div>Prospective observational cohort study.</div></div><div><h3>Setting & Population</h3><div>In total, 2,755 hypertensive patients with CKD stages 3-4, receiving care from a nephrologist, from the French CKD–Renal Epidemiology and Information Network (CKD-REIN cohort study).</div></div><div><h3>Exposure</h3><div>Patient factors, including sociodemographic characteristics, medical history, and laboratory data, and provider factors, including number of primary care physician and specialist encounters.</div></div><div><h3>Outcomes</h3><div>Changes in antihypertensive drug-class prescription during follow-up: add-on or withdrawal.</div></div><div><h3>Analytical Approach</h3><div>Hierarchical shared-frailty models to estimate hazard ratios (HR) to deal with clustering at the nephrologist level and linear mixed models to describe systolic BP trajectory.</div></div><div><h3>Results</h3><div>At baseline, median age was 69 years, and mean estimated glomerular filtration rate was 33<!--> <!-->mL/min/1.73 m². In total, 66% of patients were men, 81% had BP<!--> <!-->≥<!--> <!-->130/80<!--> <!-->mm Hg, and 75% were prescribed<!--> <!-->≥2 antihypertensive drugs. During a median 5-year follow-up, the rate of changes of antihypertensive prescription was 50 per 100 person-years, 23 per 100 for add-ons, and 25 per 100 for withdrawals. After adjusting for risk factors, systolic BP, and the number of antihypertensive drugs, poor medication adherence was associated with increased HR for add-on (1.35, 95% confidence interval [CI], 1.01-1.80), whereas a lower education level was associated with increased HR for withdrawal (1.23, 95% CI, 1.02-1.49) for 9-11 years versus<!--> <!-->≥12 years. More frequent nephrologist visits (≥4 vs none) were associated with higher HRs of add-on and withdrawal (1.52, 95% CI, 1.06-2.18; 1.57, 95% CI, 1.12-2.19, respectively), whereas associations with visit frequency to other physicians varied with their specialty. Mean systolic BP decreased by 4<!--> <!-->mm Hg following drug add-on but tended to increase thereafter.</div></div><div><h3>Limitations</h3><div>Lack of information on prescriber and drug dosing.</div></div><div><h3>Conclusions</h3><div>In patients with CKD and poor BP control, changes in antihypertensive drug prescriptions are common and relate to clinician preferences and patients’ tolerability. Sustainable reduction in systolic BP after add-on of a drug class is infrequently achieved.</div></div><div><h3>Plain-Language Summary</h3><div>Blood pressure (BP) control remains unattained in most patients with chronic kidney disease (CKD), raising questions about how antihypertensive treatment is manag
研究理由和目的控制血压对于预防慢性肾脏病(CKD)的心肾并发症至关重要,但大多数患者无法达到血压目标。我们对降压药处方和收缩压的纵向模式进行了评估。研究设计前瞻性观察性队列研究。暴露患者因素包括社会人口学特征、病史和实验室数据,医疗服务提供者因素包括初级保健医生和专科医生接诊次数。结果随访期间降压药类处方的变化:加服或停用。分析方法分层共享虚弱模型估算危险比(HR),以处理肾病医生层面的聚类问题,线性混合模型描述收缩压轨迹。结果基线时,中位年龄为 69 岁,平均肾小球滤过率为 33 mL/min/1.73 m²。66%的患者为男性,81%的患者血压≥130/80 mm Hg,75%的患者服用≥2种降压药。在中位 5 年的随访期间,降压药处方的变化率为每 100 人年 50 次,其中 23 次为加药,25 次为停药。在对危险因素、收缩压和降压药物数量进行调整后,用药依从性差与加药 HR 的增加有关(1.35,95% 置信区间 [CI],1.01-1.80),而教育水平较低与 9-11 年与≥12 年的停药 HR 的增加有关(1.23,95% CI,1.02-1.49)。肾科医生就诊次数越多(≥4 次与无次数),加药和停药的 HR 越高(分别为 1.52,95% CI,1.06-2.18;1.57,95% CI,1.12-2.19),而与其他医生就诊次数的关系则因专科而异。结论 在血压控制不佳的慢性肾脏病患者中,抗高血压药物处方的改变很常见,这与临床医生的偏好和患者的耐受性有关。白话摘要大多数慢性肾脏病(CKD)患者仍无法达到血压控制目标,这就提出了如何管理降压治疗的问题。我们的研究强调了在 5 年的随访中,接受肾科医生治疗的 CKD 3-4 期患者降压药处方的动态但异质性模式。高体重指数和用药依从性差等可改变因素与增加抗高血压药物种类的较高风险有关,与基线血压和抗高血压治疗无关。同样,较低的教育水平与停用降压药有关,更频繁地就诊于初级保健医生也与停用降压药有关,这凸显了协调护理的重要性。添加一类药物后收缩压持续降低的情况并不多见,这可能与停药和治疗依从性差有关。
{"title":"Antihypertensive Treatment Patterns in CKD Stages 3 and 4: The CKD-REIN Cohort Study","authors":"","doi":"10.1016/j.xkme.2024.100912","DOIUrl":"10.1016/j.xkme.2024.100912","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Rationale &amp; Objective&lt;/h3&gt;&lt;div&gt;Blood pressure (BP) control is essential for preventing cardiorenal complications in chronic kidney disease (CKD), but most patients fail to reach BP target. We assessed longitudinal patterns of antihypertensive drug prescription and systolic BP.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Study Design&lt;/h3&gt;&lt;div&gt;Prospective observational cohort study.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Setting &amp; Population&lt;/h3&gt;&lt;div&gt;In total, 2,755 hypertensive patients with CKD stages 3-4, receiving care from a nephrologist, from the French CKD–Renal Epidemiology and Information Network (CKD-REIN cohort study).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Exposure&lt;/h3&gt;&lt;div&gt;Patient factors, including sociodemographic characteristics, medical history, and laboratory data, and provider factors, including number of primary care physician and specialist encounters.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Outcomes&lt;/h3&gt;&lt;div&gt;Changes in antihypertensive drug-class prescription during follow-up: add-on or withdrawal.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Analytical Approach&lt;/h3&gt;&lt;div&gt;Hierarchical shared-frailty models to estimate hazard ratios (HR) to deal with clustering at the nephrologist level and linear mixed models to describe systolic BP trajectory.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;At baseline, median age was 69 years, and mean estimated glomerular filtration rate was 33&lt;!--&gt; &lt;!--&gt;mL/min/1.73 m². In total, 66% of patients were men, 81% had BP&lt;!--&gt; &lt;!--&gt;≥&lt;!--&gt; &lt;!--&gt;130/80&lt;!--&gt; &lt;!--&gt;mm Hg, and 75% were prescribed&lt;!--&gt; &lt;!--&gt;≥2 antihypertensive drugs. During a median 5-year follow-up, the rate of changes of antihypertensive prescription was 50 per 100 person-years, 23 per 100 for add-ons, and 25 per 100 for withdrawals. After adjusting for risk factors, systolic BP, and the number of antihypertensive drugs, poor medication adherence was associated with increased HR for add-on (1.35, 95% confidence interval [CI], 1.01-1.80), whereas a lower education level was associated with increased HR for withdrawal (1.23, 95% CI, 1.02-1.49) for 9-11 years versus&lt;!--&gt; &lt;!--&gt;≥12 years. More frequent nephrologist visits (≥4 vs none) were associated with higher HRs of add-on and withdrawal (1.52, 95% CI, 1.06-2.18; 1.57, 95% CI, 1.12-2.19, respectively), whereas associations with visit frequency to other physicians varied with their specialty. Mean systolic BP decreased by 4&lt;!--&gt; &lt;!--&gt;mm Hg following drug add-on but tended to increase thereafter.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Limitations&lt;/h3&gt;&lt;div&gt;Lack of information on prescriber and drug dosing.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;In patients with CKD and poor BP control, changes in antihypertensive drug prescriptions are common and relate to clinician preferences and patients’ tolerability. Sustainable reduction in systolic BP after add-on of a drug class is infrequently achieved.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Plain-Language Summary&lt;/h3&gt;&lt;div&gt;Blood pressure (BP) control remains unattained in most patients with chronic kidney disease (CKD), raising questions about how antihypertensive treatment is manag","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142586681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Kidney Injury Survivor Remote Patient Monitoring: A Single Center’s Experience and an Effectiveness Evaluation 急性肾损伤幸存者远程患者监护:单个中心的经验与效果评估
IF 3.2 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-19 DOI: 10.1016/j.xkme.2024.100905

Rationale & Objective

Remote patient monitoring (RPM) could improve the quality and efficiency of acute kidney injury (AKI) survivor care. This study described our experience with AKI RPM and characterized its effectiveness.

Study Design

A cohort study matched 1:3 to historical controls.

Setting & Participants

Patients hospitalized with an episode of AKI who were discharged home and were not treated with dialysis.

Exposure

Participation in an AKI RPM program, which included use of a home vital sign and symptom monitoring technology and weekly in-center laboratory assessments.

Outcomes

Risk of unplanned hospital readmission or emergency department (ED) visit within 6 months.

Analytic Approach

Endpoints were assessed using Cox proportional hazards models.

Results

Forty of the 49 patients enrolled in AKI RPM (82%) participated in the program after hospital discharge. Seventy three percent of patients experienced one AKI RPM alert, most commonly related to fluid status. Among those with stage 3 AKI, the risk of unplanned readmission or ED visit within 6 months of discharge was not different between AKI RPM patients (n = 34) and matched controls (n = 102) (HR 1.33 [95% CI, 0.81-2.18]; P = 0.27). The incidence of an ED visit without hospitalization was significantly higher in the AKI RPM group (HR 1.95, [95% CI, 1.05-3.62]; P = 0.035). The risk of an unplanned readmission or ED visit was higher in those with baseline eGFR < 45 mL/min/1.73 m2 exposed to AKI RPM (HR 2.24 [95% CI, 1.19-4.20]; P = 0.012) when compared with those with baseline eGFR ≥45 mL/min/1.73 m2 (HR 0.69 [95% CI, 0.29-1.67]; P = 0.41) (test of interaction P = 0.04).

Limitations

Small sample size that may have been underpowered for the effectiveness endpoints.

Conclusions

AKI RPM, when used after hospital discharge, led to alerts and interventions directed at optimizing kidney health and AKI complications but did not reduce the risk for rehospitalization.
理论依据& 目标远程患者监护(RPM)可提高急性肾损伤(AKI)幸存者护理的质量和效率。本研究介绍了我们在 AKI RPM 方面的经验,并描述了其有效性。研究设计一项队列研究,与历史对照组进行 1:3 匹配。结果6个月内发生意外再入院或急诊科就诊的风险。分析方法采用Cox比例危险模型评估终点。结果49名参加AKI RPM的患者中有40人(82%)在出院后参加了该项目。73%的患者经历过一次 AKI RPM 警报,最常见的警报与液体状态有关。在 3 期 AKI 患者中,AKI RPM 患者(34 人)与匹配对照组(102 人)在出院后 6 个月内发生意外再入院或急诊就诊的风险没有差异(HR 1.33 [95% CI, 0.81-2.18];P = 0.27)。AKI RPM 组未住院的急诊就诊发生率明显更高(HR 1.95 [95% CI, 1.05-3.62];P = 0.035)。与基线 eGFR ≥45 mL/min/1.73 m2 的患者相比(HR 0.69 [95% CI, 0.29-1.67]; P = 0.41),接受 AKI RPM 治疗的基线 eGFR ≥45 mL/min/1.73 m2 患者发生意外再入院或急诊就诊的风险更高(HR 2.24 [95% CI, 1.19-4.20]; P = 0.012)(交互作用检验 P = 0.04)。结论出院后使用AKI RPM可发出警报并采取干预措施,以优化肾脏健康和AKI并发症,但并不能降低再次住院的风险。
{"title":"Acute Kidney Injury Survivor Remote Patient Monitoring: A Single Center’s Experience and an Effectiveness Evaluation","authors":"","doi":"10.1016/j.xkme.2024.100905","DOIUrl":"10.1016/j.xkme.2024.100905","url":null,"abstract":"<div><h3>Rationale &amp; Objective</h3><div>Remote patient monitoring (RPM) could improve the quality and efficiency of acute kidney injury (AKI) survivor care. This study described our experience with AKI RPM and characterized its effectiveness.</div></div><div><h3>Study Design</h3><div>A cohort study matched 1:3 to historical controls.</div></div><div><h3>Setting &amp; Participants</h3><div>Patients hospitalized with an episode of AKI who were discharged home and were not treated with dialysis.</div></div><div><h3>Exposure</h3><div>Participation in an AKI RPM program, which included use of a home vital sign and symptom monitoring technology and weekly in-center laboratory assessments.</div></div><div><h3>Outcomes</h3><div>Risk of unplanned hospital readmission or emergency department (ED) visit within 6 months.</div></div><div><h3>Analytic Approach</h3><div>Endpoints were assessed using Cox proportional hazards models.</div></div><div><h3>Results</h3><div>Forty of the 49 patients enrolled in AKI RPM (82%) participated in the program after hospital discharge. Seventy three percent of patients experienced one AKI RPM alert, most commonly related to fluid status. Among those with stage 3 AKI, the risk of unplanned readmission or ED visit within 6 months of discharge was not different between AKI RPM patients (n<!--> <!-->=<!--> <!-->34) and matched controls (n<!--> <!-->=<!--> <!-->102) (HR 1.33 [95% CI, 0.81-2.18]; <em>P</em> <!-->=<!--> <!-->0.27). The incidence of an ED visit without hospitalization was significantly higher in the AKI RPM group (HR 1.95, [95% CI, 1.05-3.62]; <em>P</em> <!-->=<!--> <!-->0.035). The risk of an unplanned readmission or ED visit was higher in those with baseline eGFR<!--> <!-->&lt;<!--> <!-->45<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup> exposed to AKI RPM (HR 2.24 [95% CI, 1.19-4.20]; <em>P</em> <!-->=<!--> <!-->0.012) when compared with those with baseline eGFR<!--> <!-->≥45<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup> (HR 0.69 [95% CI, 0.29-1.67]; <em>P</em> <!-->=<!--> <!-->0.41) (test of interaction <em>P</em> <!-->=<!--> <!-->0.04).</div></div><div><h3>Limitations</h3><div>Small sample size that may have been underpowered for the effectiveness endpoints.</div></div><div><h3>Conclusions</h3><div>AKI RPM, when used after hospital discharge, led to alerts and interventions directed at optimizing kidney health and AKI complications but did not reduce the risk for rehospitalization.</div></div>","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142418758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Kidney Injury Associated With Red Yeast Rice (Beni-kōji) Supplement: A Report of Two Cases 与红麴(Beni-kōji)补充剂有关的急性肾损伤:两个病例的报告
IF 3.2 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-19 DOI: 10.1016/j.xkme.2024.100908
Numerous health concerns, primarily kidney injury, have been reported with the use of Beni-kōji CholesteHelp, a functional food containing red yeast rice. Here, we describe 2 cases of kidney injury caused by beni-kōji. The first case had normal kidney function before consuming the product. After several months of use, she developed hypertension. After 6 months of supplement consumption, her estimated glomerular filtration rate (eGFR) dropped to 22.5 mL/min/1.73 m2. A spot urine sample showed a urinary protein-to-creatinine ratio of 2.03 g/g, leading to the diagnosis of Fanconi syndrome. Kidney biopsy showed tubular degeneration. Thirty-five days after discontinuing the supplement, proteinuria resolved and the eGFR returned to baseline level. The second case, who had diabetes and normal kidney function, experienced severe kidney injury (eGFR, 3.5 mL/min/1.73 m2) after 4 months of Beni-kōji CholesteHelp use. He required hemodialysis for >2 weeks but recovered kidney function after the product was discontinued. Kidney biopsy showed tubular injury similar to the first case and glomeruli changes consistent with diabetic nephropathy. These cases indicate that beni-kōji use is associated with tubular toxicity. Further studies are required to identify the precise etiology and mechanism of kidney injury.
使用含有红麴的功能性食品 Beni-kōji CholesteHelp 引起了许多健康问题,主要是肾损伤。在此,我们描述了两例由 Beni-kōji 引起的肾损伤。第一个病例在服用该产品前肾功能正常。服用几个月后,她患上了高血压。服用补充剂 6 个月后,她的肾小球滤过率(eGFR)降至 22.5 mL/min/1.73 m2。点滴尿样显示尿蛋白与肌酐的比率为 2.03 g/g,因此被诊断为范科尼综合征。肾活检显示肾小管退化。停用补充剂 35 天后,蛋白尿消失,eGFR 恢复到基线水平。第二个病例患有糖尿病,肾功能正常,在服用贝尼可司胆石通 4 个月后,出现了严重的肾损伤(eGFR,3.5 mL/min/1.73 m2)。他需要进行 2 周的血液透析,但停药后肾功能恢复。肾活检显示肾小管损伤与第一个病例相似,肾小球变化与糖尿病肾病一致。这些病例表明,使用苯光吉与肾小管毒性有关。要确定肾损伤的确切病因和机制,还需要进一步的研究。
{"title":"Acute Kidney Injury Associated With Red Yeast Rice (Beni-kōji) Supplement: A Report of Two Cases","authors":"","doi":"10.1016/j.xkme.2024.100908","DOIUrl":"10.1016/j.xkme.2024.100908","url":null,"abstract":"<div><div>Numerous health concerns, primarily kidney injury, have been reported with the use of Beni-kōji CholesteHelp, a functional food containing red yeast rice. Here, we describe 2 cases of kidney injury caused by beni-kōji. The first case had normal kidney function before consuming the product. After several months of use, she developed hypertension. After 6 months of supplement consumption, her estimated glomerular filtration rate (eGFR) dropped to 22.5<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup>. A spot urine sample showed a urinary protein-to-creatinine ratio of 2.03<!--> <!-->g/g, leading to the diagnosis of Fanconi syndrome. Kidney biopsy showed tubular degeneration. Thirty-five days after discontinuing the supplement, proteinuria resolved and the eGFR returned to baseline level. The second case, who had diabetes and normal kidney function, experienced severe kidney injury (eGFR, 3.5<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup>) after 4 months of Beni-kōji CholesteHelp use. He required hemodialysis for<!--> <!-->&gt;2 weeks but recovered kidney function after the product was discontinued. Kidney biopsy showed tubular injury similar to the first case and glomeruli changes consistent with diabetic nephropathy. These cases indicate that beni-kōji use is associated with tubular toxicity. Further studies are required to identify the precise etiology and mechanism of kidney injury.</div></div>","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142528957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal Physiology Education via Podcast: Channel Your Enthusiasm 通过播客进行肾脏生理学教育:激发你的热情
IF 3.2 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-19 DOI: 10.1016/j.xkme.2024.100903
Renal physiology is considered one of the most challenging medical disciplines to understand and to teach. Eight academic nephrologists have come together to produce a podcast devoted to helping learners at any level improve their understanding of this difficult topic. Using Dr Burton D. Rose’s classic textbook: Clinical Physiology of Acid-Base and Electrolyte Disorders, the podcast faculty systematically attack each chapter of the book in a didactic yet fun-flowing interactive discussion. This education model is unique and helps demystify complex topics.
肾脏生理学被认为是最难理解和教学的医学学科之一。八位肾脏病学专家共同制作了一个播客,致力于帮助任何水平的学习者提高对这一难题的理解。使用伯顿-D-罗斯博士的经典教科书:酸碱和电解质紊乱的临床生理学》,播客教师们通过说教式但又充满乐趣的互动讨论,系统地讲解了书中的每一章。这种教育模式是独一无二的,有助于解开复杂话题的神秘面纱。
{"title":"Renal Physiology Education via Podcast: Channel Your Enthusiasm","authors":"","doi":"10.1016/j.xkme.2024.100903","DOIUrl":"10.1016/j.xkme.2024.100903","url":null,"abstract":"<div><div>Renal physiology is considered one of the most challenging medical disciplines to understand and to teach. Eight academic nephrologists have come together to produce a podcast devoted to helping learners at any level improve their understanding of this difficult topic. Using Dr Burton D. Rose’s classic textbook: <em>Clinical Physiology of Acid-Base and Electrolyte Disorders</em>, the podcast faculty systematically attack each chapter of the book in a didactic yet fun-flowing interactive discussion. This education model is unique and helps demystify complex topics.</div></div>","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Back-up Arteriovenous Fistulas in Peritoneal Dialysis Patients: A Systematic Review and Meta-analysis 腹膜透析患者的后备动静脉瘘:系统回顾和元分析
IF 3.2 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-09-19 DOI: 10.1016/j.xkme.2024.100904
<div><h3>Rationale & Objective</h3><div>Peritoneal dialysis (PD) is a dialysis modality limited by the potential need of transferring to hemodialysis. Optimal hemodialysis vascular access is an arteriovenous fistula. Back-up arteriovenous fistula (bAVF) is a strategy to prevent central venous catheter (CVC) insertion, but its use in the PD population has not been systematically reviewed.</div></div><div><h3>Study Design</h3><div>Systematic review and meta-analysis.</div></div><div><h3>Setting & Study Populations</h3><div>Studies including PD patients with a bAVF and the associated outcomes, including risk of hemodialysis transfer with a CVC and the proportion of bAVFs used.</div></div><div><h3>Selection Criteria for Studies</h3><div>Retrospective or prospective, observational studies, non-randomized or randomized controlled trials.</div></div><div><h3>Data Extractions</h3><div>Vascular access at time of hemodialysis transfer (bAVF vs CVC) for patients with and without a bAVF. The data on bAVF outcomes included bAVFs that stopped working, were never used, and the number of patients requiring hemodialysis.</div></div><div><h3>Analytical Approach</h3><div>Random-effects meta-analysis and meta-proportional analysis were conducted, with risk of bias within studies assessed using the Newcastle-Ottawa Scale.</div></div><div><h3>Results</h3><div>We screened 1,855 studies, 11 of which met the inclusion criteria, comprising 598 (62%) patients with a bAVF and 368 (38%) without. The proportion of bAVFs never used was 69% (95% confidence intervals [CI], 0.58-0.80; <em>I</em><sup>2</sup> <!-->=<!--> <!-->86.2%). Meta-analysis of 8 studies found no difference in hemodialysis transfer between patients with a bAVF and those without (hazard ratio, 1.14; 95% CI, 0.86-1.51). However, the risk of hemodialysis transfer with a CVC was significantly lower in patients with a bAVF (hazard ratio, 0.43; 95% CI, 0.17-0.68).</div></div><div><h3>Limitations</h3><div>Substantial heterogeneity between the studies and large number of studies with poor quality.</div></div><div><h3>Conclusions</h3><div>bAVF was associated with a high rate of non-utilization but a lower risk of starting hemodialysis via a CVC. Future studies assessing long-term clinical outcomes may provide further insights into the role of bAVF creation in shaping dialysis unit policies.</div></div><div><h3>Plain-Language Summary</h3><div>Peritoneal dialysis (PD) is limited by hemodialysis transfer. The optimal vascular access in hemodialysis is the arteriovenous fistula, yet requirements for maturation often necessitate a central venous catheter (CVC) insertion in acute transfers from PD. A back-up arteriovenous fistula (bAVF) is a strategy used to avoid CVC use in such situations. However, no consensus is currently available on the best approach for bAVF in PD. By conducting a systematic review, we found that 69% of bAVFs were never used. Nevertheless, bAVFs reduced the risk of hemodialysis transfer with
原理&amp; 目的腹膜透析(PD)是一种透析方式,但由于可能需要转为血液透析而受到限制。最佳的血液透析血管通路是动静脉内瘘。研究设计系统综述和荟萃分析。研究地点和范围;研究人群研究包括使用动静脉内瘘的腹膜透析患者及其相关结果,包括使用CVC进行血液透析转移的风险和使用动静脉内瘘的比例。研究的选择标准回顾性或前瞻性、观察性研究、非随机或随机对照试验。数据提取有无bAVF患者血液透析转运时的血管通路(bAVF与CVC)。分析方法采用随机效应荟萃分析和荟萃比例分析,使用纽卡斯尔-渥太华量表评估研究的偏倚风险。结果我们筛选了1855项研究,其中11项符合纳入标准,包括598名(62%)有bAVF的患者和368名(38%)无bAVF的患者。从未使用过 bAVF 的比例为 69%(95% 置信区间 [CI],0.58-0.80;I2 = 86.2%)。对 8 项研究进行的 Meta 分析发现,有 bAVF 和没有 bAVF 的患者在血液透析转运方面没有差异(危险比为 1.14;95% CI 为 0.86-1.51)。然而,bAVF患者使用CVC进行血液透析转移的风险明显较低(危险比为0.43;95% CI为0.17-0.68)。结论bAVF与较高的未使用率有关,但通过CVC开始血液透析的风险较低。未来对长期临床结果进行评估的研究可能会进一步揭示建立 bAVF 在制定透析室政策方面的作用.Plain-Language Summary腹膜透析(PD)受到血液透析转移的限制。血液透析的最佳血管通路是动静脉内瘘,但由于成熟度的要求,在急性腹膜透析转院时往往需要插入中心静脉导管(CVC)。备用动静脉内瘘 (bAVF) 是在这种情况下避免使用 CVC 的一种策略。然而,目前关于在腹膜透析患者中使用备用动静脉瘘的最佳方法尚未达成共识。通过系统回顾,我们发现 69% 的动静脉内瘘从未使用过。尽管如此,bAVF 仍将使用 CVC 进行血液透析的风险降低了近 60%。综述中的研究数量较少,异质性较高,因此需要进一步研究以明确 bAVF 在帕金森病患者中的作用和益处。
{"title":"Back-up Arteriovenous Fistulas in Peritoneal Dialysis Patients: A Systematic Review and Meta-analysis","authors":"","doi":"10.1016/j.xkme.2024.100904","DOIUrl":"10.1016/j.xkme.2024.100904","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Rationale &amp; Objective&lt;/h3&gt;&lt;div&gt;Peritoneal dialysis (PD) is a dialysis modality limited by the potential need of transferring to hemodialysis. Optimal hemodialysis vascular access is an arteriovenous fistula. Back-up arteriovenous fistula (bAVF) is a strategy to prevent central venous catheter (CVC) insertion, but its use in the PD population has not been systematically reviewed.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Study Design&lt;/h3&gt;&lt;div&gt;Systematic review and meta-analysis.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Setting &amp; Study Populations&lt;/h3&gt;&lt;div&gt;Studies including PD patients with a bAVF and the associated outcomes, including risk of hemodialysis transfer with a CVC and the proportion of bAVFs used.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Selection Criteria for Studies&lt;/h3&gt;&lt;div&gt;Retrospective or prospective, observational studies, non-randomized or randomized controlled trials.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Data Extractions&lt;/h3&gt;&lt;div&gt;Vascular access at time of hemodialysis transfer (bAVF vs CVC) for patients with and without a bAVF. The data on bAVF outcomes included bAVFs that stopped working, were never used, and the number of patients requiring hemodialysis.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Analytical Approach&lt;/h3&gt;&lt;div&gt;Random-effects meta-analysis and meta-proportional analysis were conducted, with risk of bias within studies assessed using the Newcastle-Ottawa Scale.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;We screened 1,855 studies, 11 of which met the inclusion criteria, comprising 598 (62%) patients with a bAVF and 368 (38%) without. The proportion of bAVFs never used was 69% (95% confidence intervals [CI], 0.58-0.80; &lt;em&gt;I&lt;/em&gt;&lt;sup&gt;2&lt;/sup&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;86.2%). Meta-analysis of 8 studies found no difference in hemodialysis transfer between patients with a bAVF and those without (hazard ratio, 1.14; 95% CI, 0.86-1.51). However, the risk of hemodialysis transfer with a CVC was significantly lower in patients with a bAVF (hazard ratio, 0.43; 95% CI, 0.17-0.68).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Limitations&lt;/h3&gt;&lt;div&gt;Substantial heterogeneity between the studies and large number of studies with poor quality.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;bAVF was associated with a high rate of non-utilization but a lower risk of starting hemodialysis via a CVC. Future studies assessing long-term clinical outcomes may provide further insights into the role of bAVF creation in shaping dialysis unit policies.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Plain-Language Summary&lt;/h3&gt;&lt;div&gt;Peritoneal dialysis (PD) is limited by hemodialysis transfer. The optimal vascular access in hemodialysis is the arteriovenous fistula, yet requirements for maturation often necessitate a central venous catheter (CVC) insertion in acute transfers from PD. A back-up arteriovenous fistula (bAVF) is a strategy used to avoid CVC use in such situations. However, no consensus is currently available on the best approach for bAVF in PD. By conducting a systematic review, we found that 69% of bAVFs were never used. Nevertheless, bAVFs reduced the risk of hemodialysis transfer with ","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142528657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Kidney Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1